Abstract:Panvascular disease (PVD) represents a category of systemic vascular disorders characterized by atherosclerosis as a common pathological foundation. Elevated lipid variability (LV) is not only an independent risk factor for cardiovascular disease (CVD), cerebrovascular disease, and diabetic vascular complications but is also significantly associated with increased all-cause mortality and poor prognosis. Therefore, alongside intensive lipid-lowering therapy, maintaining stable and target lipid levels is of great significance for achieving precise prevention and treatment of PVD. This article reviews the recent research progress on the correlation between LV and PVD.